Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Family Medicine
 Disease Category: Atherosclerosis
Location: United States, NC

Trial Information

TRANSLATE- Treatment with ADP receptor inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome Registry

Study enrolling patients who have had a heart attack, were treated with a procedure to open blocked blood flow in the heart, and were placed on clot-preventing medications. This study will collect information about symptoms that you may have related to your heart, the medicines you take and any health problems you may have had since your hospitalization or last phone interview. The information gathered from you and others involved in this study may provide the medical community with a better understanding of how treatments you take for your heart affect your life after you leave the hospital. An interviewer will call you about 6 weeks after your heart attack to ask you questions about your health. Interviewers will call you three more times at 6, 12, and 15 months after your heart attack. The interviews will last approximately 20 minutes.

Patient Inclusion/ Exclusion Criteria:

  • Contact center for more details.

Rebecca Palermo, RN, MS, Manager, Heart & Vascular Research Department
Rex Healthcare
4420 Lake Boone Trail
Raleigh, NC 27607
Phone: 919-784-3795
Fax: 919-784-3426
Email: rebecca.palermo@rexhealth.com

View Map

Research Center Information: Rex Healthcare

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.